0800 701 1918

Currently, the "color coding" project includes 100% of Cristália's portfolio of injectable products targeting to enable an easier identification of the drug to be administered, therefore contributing to less administration errors

  • 1997
    Projetos Sociais

    Acquisition of ampoules with colored rings * International supplier

  • 1999
    Projetos Sociais

    Implementation of the RDC333 (currently 71). Labeling of the SVPS color-coded by therapeutic class

  • 2003
    Projetos Sociais

    Implementation of the hydrogen peroxide sterilization process Sterile Pack for substances intended for neuraxial administration

  • 2009
    Projetos Sociais

    Implementation of latex-free stoppers

  • 2013
    Projetos Sociais


As most of the drug manufacturers do not supply their products in packages that meet their needs, hospital pharmacies had to develop a truly industrial-scale production line.

Most drugs that reach to medical facilities cannot be distributed and administered in a safe manner. This happens because about 70% of everything produced by pharmaceutical industry are reserved to retail market, and are not addressed to hospital settings.

Such reality led Cristália to invest on innovation in the primary packages of its products addressed to hospitals, thereby implementing the following additional innovations in its packages:

Color-Coded Labels

The Brazilian regulatory authority (ANVISA) recommended some actions, including Resolution RDC 71, addressing the implementation of color-coded tags according to the therapeutic class to which a product belongs. While this approach is interesting and feasible, this is not a mandatory procedure. In spite of that, Cristália has decided to implement the recommendation, and, once again, had a breakthrough!

Etiquetas coloridas


Cristália sought in the international market a manufacturer that could supply ampoules with colored rings, in line to the recommendations of Resolution RDC 71.

Since then, Cristália has made available to the market ampoules and vials that not only have colored labels, as suggested on RDC 71, but also engraved ampoule rings on matching colors exhibiting the “abbreviation/initials” of the drug inside it.


Sterilized Cases

One of the most significant innovations for Anesthesiology has been the introduction of the sterilized products line - Sterile Pack – for drugs/ substances that are applied right into patients’ neuroaxis (spine). The Sterile-pack case makes sure that the whole primary package of a drug is sterile and free from any contaminations, thus avoiding post-spinal puncture infections.

This brings safety both for physicians and patients.

Latex-Free Bungs

The replacement of bungs made of latex used to seal ampoule-vials for latex-free bungs is another major innovation in terms of safety, due to the high number of patients and doctors that are allergic to latex. By using this approach, Cristália’s injectable products contribute to safer surgical procedures.